MedPath

GATT Versus Canaloplasty (GVC)

Not Applicable
Recruiting
Conditions
Glaucoma, Open-Angle
Interventions
Procedure: canaloplasty
Procedure: Gonioscopy-assisted Transluminal Trabeculotomy
Registration Number
NCT05366647
Lead Sponsor
Medical University of Bialystok
Brief Summary

Study aims to compare the effectiveness and safety profile of Gonioscopy-assisted Transluminal Trabeculotomy and canaloplasty, in order to find out if one operation is superior to the other. Both procedures are performed in patients with medically uncontrolled open-angle glaucoma. Canaloplasty is a recently newly introduced procedure, which showed encouraging results without antimetabolite usage intra- and postoperatively. Gonioscopy-assisted Transluminal Trabeculotomy is the procedure that aims the same mechanism of aqueous outflow, however is perform with ab interno approach, which comprise it to the minimally invasive glaucoma surgery techniques. Purpose of the study is to compare both surgeries concerning success rate, intraocular pressure, medication burden and complications rate. So far there is no comparison of the Gonioscopy-assisted Transluminal Trabeculotomy and canaloplasty available.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria
  • 18 Years and older (Adult, Older Adult)
  • patients with confirmed uncontrolled open angle glaucoma
  • no prior glaucoma surgery (once laser trabeculoplasty or cyclophotocoagulation) allowed
Exclusion Criteria
  • angle closure glaucoma
  • congenital glaucoma
  • inflammatory glaucoma

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Gonioscopy-assisted Transluminal TrabeculotomycanaloplastyGonioscopy-assisted Transluminal Trabeculotomy ab interno
CanaloplastyGonioscopy-assisted Transluminal TrabeculotomyCanaloplasty ab externo
Primary Outcome Measures
NameTimeMethod
success rate (complete and qualified success)24 months

Success is defined: 1. IOP \< 21 mmHg and at least 20% IOP change from baseline 2. IOP \< 18 mmHg

Secondary Outcome Measures
NameTimeMethod
IOP, medication, complications24 months

intraocular pressure change, medication postoperatively, complications intra- and postoperatively

Trial Locations

Locations (1)

Ophthalmology Clinic Medical University of Bialystok

🇵🇱

Białystok, Poland

© Copyright 2025. All Rights Reserved by MedPath